Factor Therapeutics Limited (ASX:FTT) News and Share Price

Factor Therapeutics Limited (ASX: FTT) is a biotechnology company engaged in the development and commercialization of therapeutics for advanced wound care. FTT lead program, VF001 has been developed for the treatment of ulcers. Chronic ailments such as venous leg ulcers are not only very common type of wounds, but they are very painful and debilitating. FTT is also working towards the development of solutions for varied interventional wound care and serious orphan dermatological conditions.